LC/QTOF/MS/MS characterization, molecular docking and in silico toxicity prediction studies on degradation products of anagliptin

CXIX.—The formation and stability of spiro-compounds. Part I. spiro-Compounds from cyclohexane

Richard Moore Beesley, Christopher Kelk Ingold, Jocelyn Field Thorpe · Journal of the Chemical Society Transactions · 1915 · 722 citations

Natural Sciences, Chemistry, Organic Chemistry +4

Anagliptin, a potent dipeptidyl peptidase IV inhibitor: its single-crystal structure and enzyme interactions

Yukihisa S. Watanabe, Yoshika Yasuda, Yuko Kojima et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2015 · 49 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Pharmacokinetics and metabolism of [¹⁴C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans

Shinji Furuta, Clair Smart, Andrew Hackett et al. · Xenobiotica · 2012 · 38 citations

Medicine, Pharmacokinetics, Pharmacology +12

Isolation, Identification and Molecular Docking Studies of a New Isolated Compound, from Onopordon acanthium: A Novel Angiotensin Converting Enzyme (ACE) inhibitor

Niusha Sharifi, Effat Souri, Seyed Ali Ziai et al. · Journal of Ethnopharmacology · 2013 · 37 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Identification of forced degradation products of tedizolid phosphate by liquid chromatography/electrospray ionization tandem mass spectrometry

Yinping Lei, Bo Jin, Chen Ma et al. · Journal of Pharmaceutical and Biomedical Analysis · 2017 · 25 citations

Pharmacy, Biochemistry, Pharmaceutical Analysis +17